Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early radiation-induced mucosal changes evaluated by proctoscopy: predictive role of dosimetric parameters.
Ippolito E, Deodato F, Macchia G, Massaccesi M, Digesù C, Pirozzi GA, Spera G, Marangi S, Annoscia E, Cilla S, Piermattei A, Valentini V, Cellini N, Ingrosso M, Morganti AG. Ippolito E, et al. Among authors: piermattei a. Radiother Oncol. 2012 Jul;104(1):103-8. doi: 10.1016/j.radonc.2012.05.010. Epub 2012 Jun 23. Radiother Oncol. 2012. PMID: 22727263
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients.
Morganti AG, Cilla S, Valentini V, Digesu' C, Macchia G, Deodato F, Ferrandina G, Cece MG, Cirocco M, Garganese G, Di Lullo L, Traficante D, Scarabeo F, Panunzi S, De Gaetano A, Sallustio G, Cellini N, Sofo L, Piermattei A, Scambia G. Morganti AG, et al. Among authors: piermattei a. Radiother Oncol. 2009 Jan;90(1):86-92. doi: 10.1016/j.radonc.2008.10.017. Epub 2008 Nov 17. Radiother Oncol. 2009. PMID: 19010560 Clinical Trial.
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial.
Massaccesi M, Cilla S, Deodato F, Digesù C, Macchia G, Caravatta L, Ippolito E, Picardi V, Ferro M, Mignogna S, Mattiucci GC, Valentini V, Piermattei A, Morganti AG. Massaccesi M, et al. Among authors: piermattei a. Anticancer Res. 2013 Jun;33(6):2785-9. Anticancer Res. 2013. PMID: 23749942 Clinical Trial.
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma.
Morganti AG, Balducci M, Salvati M, Esposito V, Romanelli P, Ferro M, Calista F, Digesù C, Macchia G, Ianiri M, Deodato F, Cilla S, Piermattei A, Valentini V, Cellini N, Cantore GP. Morganti AG, et al. Among authors: piermattei a. Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):92-7. doi: 10.1016/j.ijrobp.2009.04.064. Epub 2009 Aug 14. Int J Radiat Oncol Biol Phys. 2010. PMID: 19683876 Clinical Trial.
Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a Phase I study.
Macchia G, Cilla S, Ferrandina G, Padula GD, Deodato F, Digesù C, Caravatta L, Picardi V, Corrado G, Piermattei A, Valentini V, Cellini N, Scambia G, Morganti AG. Macchia G, et al. Among authors: piermattei a. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1390-5. doi: 10.1016/j.ijrobp.2009.04.091. Epub 2009 Sep 30. Int J Radiat Oncol Biol Phys. 2010. PMID: 19800180 Clinical Trial.
Feasibility study of moderately accelerated intensity-modulated radiotherapy plus concurrent weekly cisplatin after induction chemotherapy in locally advanced head-and neck cancer.
Morganti AG, Mignogna S, Deodato F, Massaccesi M, Cilla S, Calista F, Serafini G, Digesú C, Macchia G, Picardi V, Caravatta L, Di Lullo L, Giglio G, Sallustio G, Piermattei A, Cellini N, Valentini V. Morganti AG, et al. Among authors: piermattei a. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1073-80. doi: 10.1016/j.ijrobp.2009.12.020. Epub 2010 May 14. Int J Radiat Oncol Biol Phys. 2011. PMID: 20472342
192 results